Regardless of whether or not you like NVCR's product, their timeline and path outlined in today's PR is standard practice.
NWBO's timeline is out of the ordinary. I understand and appreciate they wanted a reputable journal first and as a smaller biotech, they will understandably need more time, but this is getting out of hand. NWBO has a ways to go until they submit an app, my guess is approvals in mid to late 2024. I hope I'm wrong.